Nicholas Doman, DO
Orthopaedic Surgery · Adrian, MINPI 1780923763
Payments from drug & device makers
Across 74 payments — averaging $16.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$136
- Bioventus LLC$102
- Pacira Pharmaceuticals Incorporated$93
- Ferring Pharmaceuticals Inc.$88
- Zimmer Biomet$72
- Johnson & Johnson$69
- plus $684 from 24 others
What the payments were for
- Food & beverage$1,244100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 20 | $136 |
| Bioventus LLC | 5 | $102 |
| Pacira Pharmaceuticals Incorporated | 4 | $93 |
| Ferring Pharmaceuticals Inc. | 5 | $88 |
| Zimmer Biomet | 2 | $72 |
| Johnson & Johnson | 5 | $69 |
| Smith+Nephew | 2 | $61 |
| Pacira Therapeutics, Inc. | 2 | $58 |
| Vericel Corporation | 2 | $40 |
| Heraeus Medical, LLC. | 2 | $37 |
| Solventum Corporation | 2 | $37 |
| Nabriva Therapeutics, PLC | 2 | $36 |
| Avanos Medical | 1 | $35 |
| Orthofix Medical, Inc. | 2 | $34 |
| Linvatec Corporation | 1 | $31 |
| Heron Therapeutics, Inc. | 2 | $29 |
| Melinta Therapeutics, LLC | 2 | $29 |
| Stryker | 1 | $27 |
| Paragon 28, Inc. | 1 | $25 |
| Sanara Medtech Inc. | 1 | $24 |
| Vertex | 1 | $23 |
| Convatec Inc. | 1 | $23 |
| FX Shoulder Solutions, Inc | 1 | $21 |
| Pinnacle, Inc | 1 | $20 |
| Mallinckrodt Enterprises LLC | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Fidia Pharma USA Inc. | 1 | $18 |
| Medtronic | 1 | $16 |
| KCI USA, Inc. | 1 | $13 |
| Pfizer | 1 | $11 |
How this compares
$1,244 in reported general payments places this provider in the 30th percentile of 829 orthopaedic surgery providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 149 | $333 |
| Ondansetron Hcl | 25 | $195 |
| Cefadroxil | 21 | $192 |
| Diclofenac Sodium | 12 | $167 |
| Oxycodone Hcl | 22 | $141 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $111 |
| Tramadol Hcl | 39 | $94 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Adrian
- Asheesh BediAnn Arbor$9.4M
- Jerome WiaterBeverly Hills$5.7M
- Jad KhalilSouthfield$3.7M
- Mark PintoChelsea$3.2M
- Kyle AndersonBingham Farms$3.1M
- Stephen BartolDetroit$2.6M
- Jeffrey FischgrundSouthfield$1.8M
- David MarkelSouthfield$1.7M
- Richard EastonRochester Hills$1.6M
- Shariff BishaiTroy$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.